Breast Biopsy Market Size

Request Free Sample Copy

Report ID: 747
Published Date: Jun 13, 2025
Report Format: PDF, PPT

Buy Now

Breast Biopsy Market Outlook:

Breast Biopsy Market size was valued at USD 2.13 billion in 2024 and is expected to reach USD 3.92 billion by 2034, expanding at around 6.3% CAGR during the forecast period i.e., between 2025-2034. In the year 2025, the industry size of breast biopsy is assessed at USD 2.24 billion.

The market growth is mainly due to increasing cases of breast cancer. According to the World Health Organization (WHO), by the end of 2020, 711 million women had been diagnosed with breast cancer in the past 5 years, making it the most common cancer in the world. In addition, government initiatives around the world to develop and implement new screening programs, raise awareness of treatment options, and organize free camps are expected to be the driving force for the global market development.

Browse key industry insights with market data tables & charts from the report:

Breast Biopsy Market Forecast | $3.92 billion Size by 2034

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of breast biopsy is assessed at USD 2.24 billion.

Breast Biopsy Market size was valued at USD 2.13 billion in 2024 and is expected to reach USD 3.92 billion by 2034, expanding at around 6.3% CAGR during the forecast period i.e., between 2025-2034.

Asia Pacific is anticipated to hold largest industry share of 35% by 2034.

The key market players include Hologic, Inc., Danaher CorporationBD (Becton, Dickinson, and Company)Cook Medical LLCArgon Medical Devices, Inc.B. Braun Melsungen AGC.R. Bard, Inc.Devicor Medical Products, Inc.Cardinal Health, Inc.